메뉴 건너뛰기




Volumn 117, Issue 10, 2009, Pages 716-723

Anti-angiogenic factor endostatin in osteosarcoma

Author keywords

Angiogenesis; Endostatin; Osteosarcoma

Indexed keywords

ENDOSTATIN; VASCULOTROPIN;

EID: 70349320569     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2009.02524.x     Document Type: Article
Times cited : (24)

References (28)
  • 2
    • 0028870050 scopus 로고
    • Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
    • Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995 92 : 768 772.
    • (1995) Proc Natl Acad Sci USA , vol.92 , pp. 768-772
    • Shweiki, D.1    Neeman, M.2    Itin, A.3    Keshet, E.4
  • 3
    • 0031454617 scopus 로고    scopus 로고
    • Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
    • O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997 88 : 277 285.
    • (1997) Cell , vol.88 , pp. 277-285
    • O'Reilly, M.S.1    Boehm, T.2    Shing, Y.3    Fukai, N.4    Vasios, G.5    Lane, W.S.6
  • 4
    • 0027970092 scopus 로고
    • Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
    • O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994 79 : 315 328.
    • (1994) Cell , vol.79 , pp. 315-328
    • O'Reilly, M.S.1    Holmgren, L.2    Shing, Y.3    Chen, C.4    Rosenthal, R.A.5    Moses, M.6
  • 6
    • 0034672644 scopus 로고    scopus 로고
    • Generation and degradation of human endostatin proteins by various proteinases
    • Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 2000 486 : 247 251.
    • (2000) FEBS Lett , vol.486 , pp. 247-251
    • Ferreras, M.1    Felbor, U.2    Lenhard, T.3    Olsen, B.R.4    Delaisse, J.5
  • 10
    • 18844467502 scopus 로고    scopus 로고
    • Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
    • Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000 6 : 572 577.
    • (2000) Clin Cancer Res , vol.6 , pp. 572-577
    • Kaya, M.1    Wada, T.2    Akatsuka, T.3    Kawaguchi, S.4    Nagoya, S.5    Shindoh, M.6
  • 11
    • 0033166894 scopus 로고    scopus 로고
    • Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma
    • Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999 35 : 1089 1093.
    • (1999) Eur J Cancer , vol.35 , pp. 1089-1093
    • Lee, Y.H.1    Tokunaga, T.2    Oshika, Y.3    Suto, R.4    Yanagisawa, K.5    Tomisawa, M.6
  • 12
    • 0020059356 scopus 로고
    • Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
    • Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982 49 : 1221 1230.
    • (1982) Cancer , vol.49 , pp. 1221-1230
    • Rosen, G.1    Caparros, B.2    Huvos, A.G.3    Kosloff, C.4    Nirenberg, A.5    Cacavio, A.6
  • 13
    • 33947693893 scopus 로고    scopus 로고
    • Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer
    • Zlobec I, Minoo P, Baker K, Haegert D, Khetani K, Tornillo L, et al. Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer. Eur J Cancer 2007 43 : 1101 1107.
    • (2007) Eur J Cancer , vol.43 , pp. 1101-1107
    • Zlobec, I.1    Minoo, P.2    Baker, K.3    Haegert, D.4    Khetani, K.5    Tornillo, L.6
  • 14
    • 33747624927 scopus 로고    scopus 로고
    • Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer
    • Zlobec I, Steele R, Michel RP, Compton CC, Lugli A, Jass JR. Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. Mod Pathol 2006 19 : 1236 1242.
    • (2006) Mod Pathol , vol.19 , pp. 1236-1242
    • Zlobec, I.1    Steele, R.2    Michel, R.P.3    Compton, C.C.4    Lugli, A.5    Jass, J.R.6
  • 15
    • 0035871306 scopus 로고    scopus 로고
    • Serum endostatin levels are elevated in patients with soft tissue sarcoma
    • Feldman AL, Pak H, Yang JC, Alexander HR Jr., Libutti SK. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer 2001 91 : 1525 1529.
    • (2001) Cancer , vol.91 , pp. 1525-1529
    • Feldman, A.L.1    Pak, H.2    Yang, J.C.3    Alexander, Jr.H.R.4    Libutti, S.K.5
  • 16
    • 0025141337 scopus 로고
    • What is the evidence that tumors are angiogenesis dependent?
    • Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990 82 : 4 6.
    • (1990) J Natl Cancer Inst , vol.82 , pp. 4-6
    • Folkman, J.1
  • 18
  • 19
    • 0037110699 scopus 로고    scopus 로고
    • Serum endostatin predicts tumor vascularity in hepatocellular carcinoma
    • Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, et al. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer 2002 95 : 2188 2195.
    • (2002) Cancer , vol.95 , pp. 2188-2195
    • Dhar, D.K.1    Ono, T.2    Yamanoi, A.3    Soda, Y.4    Yamaguchi, E.5    Rahman, M.A.6
  • 21
    • 43049107543 scopus 로고    scopus 로고
    • Expression pattern and circulating levels of endostatin in patients with pancreas cancer
    • Ohlund D, Ardnor B, Oman M, Naredi P, Sund M. Expression pattern and circulating levels of endostatin in patients with pancreas cancer. Int J Cancer 2008 122 : 2805 2810.
    • (2008) Int J Cancer , vol.122 , pp. 2805-2810
    • Ohlund, D.1    Ardnor, B.2    Oman, M.3    Naredi, P.4    Sund, M.5
  • 22
    • 0037108103 scopus 로고    scopus 로고
    • Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma
    • Feldman AL, Alexander HR Jr., Yang JC, Linehan WM, Eyler RA, Miller MS, et al. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 2002 95 : 1637 1643.
    • (2002) Cancer , vol.95 , pp. 1637-1643
    • Feldman, A.L.1    Alexander, Jr.H.R.2    Yang, J.C.3    Linehan, W.M.4    Eyler, R.A.5    Miller, M.S.6
  • 23
    • 0037845038 scopus 로고    scopus 로고
    • Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma
    • Bono P, Teerenhovi L, Joensuu H. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma. Cancer 2003 97 : 2767 2775.
    • (2003) Cancer , vol.97 , pp. 2767-2775
    • Bono, P.1    Teerenhovi, L.2    Joensuu, H.3
  • 24
    • 0034638790 scopus 로고    scopus 로고
    • Antibodies to endostatin in a multifocal glioblastoma patient
    • Ratel D, Nasser V, Dupre I, Benabid AL, Berger F. Antibodies to endostatin in a multifocal glioblastoma patient. Lancet 2000 356 : 1656 1657.
    • (2000) Lancet , vol.356 , pp. 1656-1657
    • Ratel, D.1    Nasser, V.2    Dupre, I.3    Benabid, A.L.4    Berger, F.5
  • 25
    • 1642482608 scopus 로고    scopus 로고
    • Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer
    • Zhao J, Yan F, Ju H, Tang J, Qin J. Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer. Cancer Lett 2004 204 : 87 95.
    • (2004) Cancer Lett , vol.204 , pp. 87-95
    • Zhao, J.1    Yan, F.2    Ju, H.3    Tang, J.4    Qin, J.5
  • 27
    • 33751403599 scopus 로고    scopus 로고
    • Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
    • Schips L, Dalpiaz O, Lipsky K, Langner C, Rehak P, Puerstner P, et al. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group. Eur Urol 2007 51 : 168 173.
    • (2007) Eur Urol , vol.51 , pp. 168-173
    • Schips, L.1    Dalpiaz, O.2    Lipsky, K.3    Langner, C.4    Rehak, P.5    Puerstner, P.6
  • 28
    • 33744466541 scopus 로고    scopus 로고
    • Antiangiogenic therapy: A universal chemosensitization strategy for cancer?
    • Kerbel RS. Antiangiogenic therapy: a universal chemosensitization strategy for cancer? Science (New York) 2006 312 : 1171 1175.
    • (2006) Science (New York) , vol.312 , pp. 1171-1175
    • Kerbel, R.S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.